Author details

Full Name

Michael C FrÃ¼hwald

Affiliation

ORCID

Career Start Year

1998

Papers

211

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37875569	Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.	Nat Med	2024
37584291	Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndrome.	Haematologica	2024
37792584	TRIM28 inactivation in epithelial nephroblastoma is frequent and often associated with predisposing TRIM28 germline variants.	J Pathol	2024
36670283	[F]FET-PET in children and adolescents with central nervous system tumors: does it support difficult clinical decision-making?		2023
38089834	Current Molecular and Clinical Landscape of ATRT - The Link to Future Therapies.		2023
37969088	SWI/SNF-deficient tumors of the central nervous system: An update.		2023
37553222	Rhabdoid tumors in patients conceived following ART: is there an association?		2023
37686571	Locally Advanced Adrenocortical Carcinoma in Children and Adolescents-Enigmatic and Challenging Cases.		2023
37219662	A Carboxy-terminal Smarcb1 Point Mutation Induces Hydrocephalus Formation and Affects AP-1 and Neuronal Signalling Pathways in Mice.	Cell Mol Neurobiol	2023
36905830	Comprehensive neurological evaluation of a cohort of patients with neurofibromatosis type 1 from a single institution.		2023
37450044	Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics.	Acta Neuropathol	2023
37308967	Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with Osteosarcoma and Ependymoma.	Hered Cancer Clin Pract	2023
36929532	Development and preliminary validation of the Sleep Screening for Children and Adolescents with Complex Chronic Conditions (SCAC).		2023
36928815	Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.	Nat Med	2023
37228432	Changes in behavior and quality of life in German young children during the COVID-19 pandemic-results from the COVID kids bavaria study.	Front Pediatr	2023
34636137	Infantile myofibromatosis: Excellent prognosis but also rare fatal progressive disease. Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.	Pediatr Blood Cancer	2022
35974385	Genotype-phenotype associations within the Li-Fraumeni spectrum: a report from the German Registry.	J Hematol Oncol	2022
35713653	Neurofibromatosis type 1: A comparison of the 1997 NIH and the 2021 revised diagnostic criteria in 75Â children and adolescents.	Genetics in Medicine	2022
35900840	Key factors for effective mitotane therapy in children with adrenocortical carcinoma.		2022
35446794	SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome.	Am J Surg Pathol	2022
36291828	Renal Medullary Carcinomas Harbor a Distinct Methylation Phenotype and Display Aberrant Methylation of Genes Related to Early Nephrogenesis.	Cancers	2022
35951611	Longitudinal change in SARS-CoV-2 seroprevalence in 3-to 16-year-old children: The Augsburg Plus study.	PLoS One	2022
35501487	ATRT-SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance.	Acta Neuropathol	2022
35565313	Infants and Newborns with Atypical Teratoid Rhabdoid Tumors (ATRT) and Extracranial Malignant Rhabdoid Tumors (eMRT) in the EU-RHAB Registry: A Unique and Challenging Population.	Cancers (Basel)	2022
36137663	MR Imaging and Clinical Characteristics of Diffuse Glioneuronal Tumor with Oligodendroglioma-like Features and Nuclear Clusters.	AJNR Am J Neuroradiol	2022
36127323	Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors.	Cell Death Dis	2022
35784570	Adrenocortical Tumors and Pheochromocytoma/Paraganglioma Initially Mistaken as Neuroblastoma-Experiences From the GPOH-MET Registry.	Frontiers in Endocrinology	2022
36497345	Proton Beam Therapy for Pediatric Tumors of the Central Nervous System-Experiences of Clinical Outcome and Feasibility from the KiProReg Study.	Cancers (Basel)	2022
36612221	Outcome for Pediatric Adreno-Cortical Tumors Is Best Predicted by the COG Stage and Five-Item Microscopic Score-Report from the German MET Studies.		2022
36455267	Neurosurgery for eloquent lesions in children: state-of-the-art rationale and technical implications of perioperative neurophysiology.	Neurosurgical Focus	2022
33283872	Corrigendum to: Molecular subgrouping of atypical teratoid/rhabdoid tumors-a reinvestigation and current consensus.	Neuro Oncol	2022
35318328	Single-cell transcriptomics identifies potential cells of origin of MYC rhabdoid tumors.	Nat Commun	2022
35173482	Current and Emerging Therapeutic Approaches for Extracranial Malignant Rhabdoid Tumors.	Cancer Management and Research	2022
35152461	Low-grade diffusely infiltrative tumour (LGDIT), SMARCB1-mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT-MYC.	Neuropathol Appl Neurobiol	2022
34950979	The need for tumor surveillance of children and adolescents with cancer predisposition syndromes: a retrospective cohort study in a tertiary-care children's hospital.	European Journal of Pediatrics	2022
34415989	Age, American Thyroid Association Risk Group, and Response to Therapy Are Prognostic Factors in Children With Differentiated Thyroid Cancer.	Journal of Clinical Endocrinology and Metabolism	2022
35327779	Exploring the Mechanisms Underlying the Effectiveness of Psychosocial Aftercare in Pediatric Chronic Pain Treatment: A Qualitative Approach.	Children	2022
34702878	Influence of Turkish origin on hematology reference intervals in the German population.	Sci Rep	2021
33481105	Supratentorial ependymoma in childhood: more than just RELA or YAP.	Acta Neuropathol	2021
34117161	Overgrowth-associated partial trisomy 15q24.3-qter and mosaic 11p15.5 duplication involving Silver-Russell region in a patient with lateralized asymmetry and developmental delay.	Clinical Dysmorphology	2021
33532948	Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group.	Fam Cancer	2021
33739782	Atypical Teratoid/Rhabdoid Tumor (AT/RT) With Molecular Features of Pleomorphic Xanthoastrocytoma.	Am J Surg Pathol	2021
34003336	Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors.	Acta Neuropathol	2021
33896072	Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor.	Genes Chromosomes Cancer	2021
33682326	Pseudohypoxic pheochromocytomas and paragangliomas dominate in children.	Pediatric Blood and Cancer	2021
34050933	A Study of Regulatory Challenges of Pediatric Oncology Phase I/II Trial Submissions and Guidance on Protocol Development.	Clin Pharmacol Ther	2021
33999421	SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type.	J Pathol	2021
33565284	High-resolution pediatric reference intervals for 15 biochemical analytes described using fractional polynomials.	Clin Chem Lab Med	2021
34101994	Evidence for a low-penetrant extended phenotype of rhabdoid tumor predisposition syndrome type 1 from a kindred with gain of SMARCB1 exon 6.	Pediatr Blood Cancer	2021
33938067	Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup.	Brain Pathol	2021